Focused Wealth Management, Inc - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,587
-15.9%
1000.0%0.00%
Q2 2023$1,887
+391.4%
1000.0%0.00%
Q1 2023$384
-22.6%
1000.0%0.00%
Q4 2022$4961000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$0
-100.0%
100
-20.0%
0.00%
Q1 2022$1,0000.0%1250.0%0.00%
Q4 2021$1,0000.0%1250.0%0.00%
Q3 2021$1,0000.0%125
+25.0%
0.00%
Q2 2021$1,0000.0%1000.0%0.00%
Q1 2021$1,0000.0%1000.0%0.00%
Q4 2020$1,0001000.0%0.00%
Q3 2020$01000.0%0.00%
Q2 2020$01000.0%0.00%
Q1 2020$0
-100.0%
1000.0%0.00%
Q4 2019$1,0001000.0%0.00%
Q3 2019$01000.0%0.00%
Q2 2019$01000.0%0.00%
Q1 2019$01000.0%0.00%
Q4 2018$0
-100.0%
1000.0%0.00%
Q3 2018$1,0000.0%1000.0%0.00%
Q2 2018$1,0000.0%1000.0%0.00%
Q1 2018$1,0000.0%1000.0%0.00%
Q4 2017$1,0000.0%1000.0%0.00%
Q3 2017$1,0000.0%1000.0%0.00%
Q2 2017$1,0001000.0%0.00%
Q1 2017$01000.0%0.00%
Q4 2016$01000.0%0.00%
Q3 2016$01000.0%0.00%
Q2 2016$0
-100.0%
1000.0%0.00%
-100.0%
Q1 2016$1,0000.0%1000.0%0.00%0.0%
Q4 2015$1,0000.0%1000.0%0.00%0.0%
Q3 2015$1,0000.0%1000.0%0.00%0.0%
Q2 2015$1,0000.0%1000.0%0.00%0.0%
Q1 2015$1,0000.0%1000.0%0.00%0.0%
Q4 2014$1,0000.0%1000.0%0.00%0.0%
Q3 2014$1,0000.0%1000.0%0.00%0.0%
Q2 2014$1,0000.0%1000.0%0.00%0.0%
Q1 2014$1,0000.0%1000.0%0.00%0.0%
Q4 2013$1,000
-50.0%
1000.0%0.00%
-50.0%
Q3 2013$2,0001000.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders